Search
Searching with a thematic focus on Health systems, HIV and AIDS treatment and care, HIV and AIDS
Showing 41-50 of 107 results
Pages
- Document
Scaling-up anti-retroviral treatment and human resources for health: what are the challenges in sub-Saharan Africa?
Swiss Agency for Development and Cooperation, 2004This document, commissioned by the Swiss Agency for Development and Cooperation (SDC), assesses human resources for health (HRH) constraints for scaling up antiretroviral therapy (ART) and identifies strategies for overcoming them. The paper also includes a case study of scaling up a project in Tanzania.DocumentHuman resources for health and ART scale-up in sub-Saharan Africa: A background paper for the MSF Access to Essential Drugs Campaign
Access to Essential Medicines Campaign, MSF, 2005This report, prepared as a background paper for the MSF Access to Essential Drugs Campaign, examines how the current human resources for health (HRH) situation in sub-Saharan Africa will affect attempts to scale up ART (anti-retroviral therapy) delivery. The current HRH crisis is characterised by workforce shortages, poor distribution of workers, and migration of skilled staff to other countries.DocumentResponding to HIV/AIDS in Africa: a comparative analysis of responses to the Abuja Declaration in Kenya, Malawi, Nigeria and Zimbabwe
ActionAid International, 2004This ActionAid publication compares the achievements and challenges of four African countries – Kenya, Malawi, Nigeria and Zimbabwe – in relation to the 2001 Abuja Declaration. The primary goal of the Abuja Declaration was to reverse the rate of HIV infection, TB and other related infectious diseases.DocumentAntiretroviral therapy in primary healthcare: Experience of the Khayelitsha programme in South Africa
World Health Organization, 2003This paper, published by the World Health Organization, discusses the experience of a Médecins Sans Frontières programme to offer antiretroviral (ARV) treatment within primary health care centres in Khayelitsha township, Cape Town, South Africa.It provides an overview of the treatment programme, and outlines a range of positive outcomes.These include dramatic improvements in health aDocumentRapid expansion, emerging challenges
Access to Essential Medicines Campaign, MSF, 2004This MSF briefing document describes some of the progress on antiretroviral therapy (ART), as well as some of the emerging operational and clinical challenges. It presents this information from the perspective of a medical humanitarian organisation that provides treatment to people living with HIV/AIDS in resource poor settings.DocumentAccess to medicines in under-served markets: what are the implications of changes in intellectual property rights, trade and drug registration policy?
Department for International Development Health Systems Resource Centre, 2004This research paper from the DFID Health Systems Resource Centre shows that the laws on Trade-Related Aspects of Intellectual Property (TRIPS) are having a negative effect on health systems in developing countries.The report brings together findings from seven studies commissioned by DFID on the public health implications of TRIPS for developing countries and the effect it has on access to drugDocumentWillingness and ability to use TRIPs flexibilities: Kenya case study
Department for International Development Health Systems Resource Centre, 2004This paper, produced by the HSRC, examines legislation and policy in light of recent developments in the international intellectual property rights framework, focusing on Kenya as a case study. It examines existing supply sources and associated trends in the pricing of medicine and the existing legal structure and flexibilities.DocumentA survey of policy and practice on the use of access to medicines-related TRIPs flexibilities in Malawi
Department for International Development Health Systems Resource Centre, 2004This HSRC study surveys Malawian policy and practice on the use of access to medicines-related TRIPs (Trade Related Aspects of Intellectual Property Rights) flexibilities, as Malawian patent legislation will need to become compliant with TRIPs by January 2006.DocumentEmerging challenges and opportunities in drug registration and regulation in developing countries
Department for International Development Health Systems Resource Centre, 2004This HSRC study describes how current drug regulation and registration processes affect the quality and availability of medicines in developing countries, and provides policy recommendations as to how systems can more efficiently allow appropriate quality drugs to market.DocumentProcesses and issues for improving access to medicines: the evidence base for domestic production and greater access to medicines
Department for International Development Health Systems Resource Centre, 2004This HSRC study explores whether the domestic production of HIV/AIDS, TB and malaria drugs in sub-Saharan Africa is sufficiently profitable to operate indefinitely, while at the same time increasing access to medicines by providing them at prices lower than from international sources. The study uses a model to simulate the cost structure of an imaginary enterprise manufacturing quality drugs.Pages
